Danaher Corp

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Life Sciences Tools & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  177693.5

• Ticker

  DHR.N

• ISIN

  US2358511028

• IPO date

  1969-12-10

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-21

• Date fact. publication of reports

  2023-12-31

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics, which offers analytical instruments, reagents, consumables, software and services, and Environmental & Applied Solutions, which offers products and services that help protect important resources and keep global food and water supplies safe. Its business research and development, manufacturing, sales, distribution, service and administrative facilities are located in over 60 countries.